Key facts
- CorWave’s last known valuation is $108.7M.
- It has raised $102.8M; the latest was Later Stage VC ($33.9M) in May 2024.
- Notable investors include Bpifrance, MedTech Innovator, La French Tech, Agoranov, Novo Holdings — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for CorWave
- ·The full record, as it builds
Funding rounds
No funding rounds for CorWave are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CorWave
Developer of innovative implanted cardiac support devices designed to help patients suffering from heart failure and offer them an active life. The company's devices consist of an implantable heart pump based on wave membrane pumping technology, enabling patients to lessen their suffering from complications and reduce the pain and burden from invasive surgery.
- Sector
- Healthcare
- HQ
- Clichy, France
- Founded
- 2011
- Employees
- 112
- Website
- corwave.com/
- Ownership
- Privately Held (backing)
CorWave doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CorWave shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CorWave in its N-PORT filings yet. We sweep new filings monthly.